Form 4: Bicycle Therapeutics CEO Kevin Lee Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Bicycle Therapeutics CEO Kevin Lee sold shares on April 2nd and 3rd, 2025, to cover statutory tax withholding obligations related to the vesting and settlement of restricted stock units.
Summary
- Kevin Lee, CEO of Bicycle Therapeutics PLC, sold a portion of his holdings in the company's ordinary shares on April 2nd and 3rd, 2025.
- The sales were executed to cover statutory tax withholding obligations associated with the vesting and settlement of restricted stock units.
- On April 2nd, 2,237 shares were sold at a weighted average price of $8.02, with individual transactions ranging from $8.00 to $8.12.
- On April 3rd, 3,432 shares were sold at a weighted average price of $7.48, with individual transactions ranging from $7.43 to $7.50.
- Following these transactions, Lee directly owns 486,265 ordinary shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, which is a common practice for executives.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It's common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | CEO Kevin Lee sold 2,237 ordinary shares at a weighted average price of $8.02. |
| 04/03/2025 | CEO Kevin Lee sold 3,432 ordinary shares at a weighted average price of $7.48. |
| 04/04/2025 | Date of the Form 4 filing. |
Keywords
Bicycle Therapeutics, Kevin Lee, share sale, tax obligations, restricted stock units, BCYC, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.